Payment overview · 2025
General Payments
$19.75
1 reported records · 1 companies
Healthcare provider profile · identity verified
Armando Luis Munoz, 14155
Allopathic & Osteopathic Physicians|General Practice · JUANA DIAZ, PR · NPI 1336353184
Verified facts
What the public records show
CMS Open Payments records show Armando Luis Munoz, 14155 received $19.75 in general payments during 2025 across 1 reported records.
PFIZER INC. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
A separate comparison found the same explicitly named product in public Medicare Part D data: Paxlovid.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 140 claims for Eliquis by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported PAXLOVID as an associated drug or biological on 24465 records involving 15715 distinct recipient NPIs. Public Medicare Part D data also shows 23 claims for Paxlovid by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| PFIZER INC. | Unresolved — no canonical attribution shown | $19.75 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $19.75 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| PAXLOVID Normalized: paxlovid |
Drug | PFIZER INC. | $19.75 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| PAXLOVID paxlovid |
2025 | Paxlovid | 2024 | 23 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
140 | 24 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | PAXLOVID open payments reported associated product |
CMS Open Payments — General Payments 24465 supporting records · 15715 recipient NPIs · example record 1228794432 |
Paxlovid · 2024 Exact normalized brand match · 1 Part D row |
23 | 23 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 2001 | 321 |
| Gabapentin | Gabapentin | 1369 | 266 |
| Lisinopril | Lisinopril | 1344 | 210 |
| Metformin Hcl | Metformin Hcl | 1243 | 194 |
| Omeprazole | Omeprazole | 929 | 178 |
| Losartan Potassium | Losartan Potassium | 875 | 155 |
| Simvastatin | Simvastatin | 842 | 137 |
| Hydrochlorothiazide | Hydrochlorothiazide | 783 | 122 |
| Famotidine | Famotidine | 663 | 182 |
| Amlodipine Besylate | Amlodipine Besylate | 614 | 99 |
| Alendronate Sodium | Alendronate Sodium | 558 | 83 |
| Montelukast Sodium | Montelukast Sodium | 558 | 194 |
| Levothyroxine Sodium | Levothyroxine Sodium | 500 | 86 |
| Tamsulosin Hcl | Tamsulosin Hcl | 461 | 87 |
| Glipizide | Glipizide | 420 | 62 |
| Metoprolol Tartrate | Metoprolol Tartrate | 417 | 66 |
| Azithromycin | Azithromycin | 376 | 342 |
| Synthroid | Levothyroxine Sodium | 368 | 61 |
| Carvedilol | Carvedilol | 346 | 62 |
| Finasteride | Finasteride | 311 | 50 |
| Pantoprazole Sodium | Pantoprazole Sodium | 305 | 58 |
| Furosemide | Furosemide | 304 | 54 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 277 | 56 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 239 | 39 |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 233 | 40 |
| Metoprolol Succinate | Metoprolol Succinate | 231 | 45 |
| Nabumetone | Nabumetone | 221 | 109 |
| Clopidogrel | Clopidogrel Bisulfate | 216 | 48 |
| Gemfibrozil | Gemfibrozil | 212 | 43 |
| Advocate Syringes | Syringe-Needle,insulin,0.5 Ml | 209 | 40 |
| Latanoprost | Latanoprost | 191 | 35 |
| Ibuprofen | Ibuprofen | 186 | 124 |
| Naproxen | Naproxen | 185 | 93 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 182 | 26 |
| Baclofen | Baclofen | 179 | 116 |
| Glimepiride | Glimepiride | 169 | 27 |
| Nifedipine Er | Nifedipine | 166 | 28 |
| Dexamethasone | Dexamethasone | 162 | 143 |
| Eliquis | Apixaban | 140 | 24 |
| Atenolol | Atenolol | 133 | 21 |
| Allopurinol | Allopurinol | 125 | 23 |
| Fluticasone Propionate | Fluticasone Propionate | 120 | 44 |
| Meloxicam | Meloxicam | 112 | 59 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 111 | 102 |
| Betamethasone Valerate | Betamethasone Valerate | 107 | 58 |
| Fenofibrate | Fenofibrate Nanocrystallized | 105 | 21 |
| Irbesartan | Irbesartan | 104 | 14 |
| Temazepam | Temazepam | 98 | 27 |
| Enalapril Maleate | Enalapril Maleate | 97 | 16 |
| Meclizine Hcl | Meclizine Hcl | 95 | 46 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 94 | 14 |
| Donepezil Hcl | Donepezil Hcl | 90 | 18 |
| Humulin N | Insulin Nph Human Isophane | 88 | 14 |
| Spironolactone | Spironolactone | 87 | 15 |
| Brimonidine Tartrate | Brimonidine Tartrate | 84 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 80 | 74 |
| Sertraline Hcl | Sertraline Hcl | 78 | 15 |
| Oxybutynin Chloride | Oxybutynin Chloride | 76 | 15 |
| Pentoxifylline | Pentoxifylline | 76 | 13 |
| Clonazepam | Clonazepam | 75 | 24 |
| Jentadueto | Linagliptin/Metformin Hcl | 75 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 72 | 18 |
| Sure Comfort | Syringe-Needle,insulin,0.5 Ml | 72 | 16 |
| Amitriptyline Hcl | Amitriptyline Hcl | 71 | 15 |
| Pravastatin Sodium | Pravastatin Sodium | 68 | 12 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 67 | 21 |
| Methylprednisolone | Methylprednisolone | 65 | 63 |
| Ezetimibe | Ezetimibe | 61 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 61 | 16 |
| Jardiance | Empagliflozin | 60 | 13 |
| Cephalexin | Cephalexin | 56 | 54 |
| Hydralazine Hcl | Hydralazine Hcl | 55 | 14 |
| Sulindac | Sulindac | 52 | 21 |
| Insulin Syringe | Syringe And Needle,insulin,1ml | 47 | 12 |
| Prednisone | Prednisone | 47 | 41 |
| Chlorthalidone | Chlorthalidone | 46 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 46 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 45 | 17 |
| Humalog | Insulin Lispro | 44 | suppressed |
| Risperidone | Risperidone | 44 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 43 | 20 |
| Clindamycin Hcl | Clindamycin Hcl | 42 | 39 |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 42 | 23 |
| Memantine Hcl | Memantine Hcl | 41 | suppressed |
| Sure Comfort | Syring-Needl,disp,insul,0.3 Ml | 41 | suppressed |
| Timolol Maleate | Timolol Maleate | 41 | suppressed |
| Fenofibrate | Fenofibrate | 40 | suppressed |
| Neomycin-Polymyxin-Hydrocort | Neomycin/Polymyxin B/Hydrocort | 40 | 36 |
| Dicyclomine Hcl | Dicyclomine Hcl | 38 | 28 |
| Levetiracetam | Levetiracetam | 38 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 38 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 36 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 36 | 33 |
| Advocate Syringes | Syringe And Needle,insulin,1ml | 35 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 35 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 33 | suppressed |
| Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 33 | 32 |
| Orphenadrine Citrate Er | Orphenadrine Citrate | 32 | 32 |
| Amiodarone Hcl | Amiodarone Hcl | 30 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 30 | suppressed |
| Mupirocin | Mupirocin | 29 | 17 |
| Alprazolam | Alprazolam | 28 | suppressed |
| Valsartan | Valsartan | 28 | suppressed |
| Captopril | Captopril | 27 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 26 | suppressed |
| Levofloxacin | Levofloxacin | 26 | 25 |
| Terazosin Hcl | Terazosin Hcl | 26 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 25 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 25 | suppressed |
| Indapamide | Indapamide | 25 | suppressed |
| Lactulose | Lactulose | 25 | suppressed |
| Calcitriol | Calcitriol | 24 | suppressed |
| Cilostazol | Cilostazol | 24 | suppressed |
| Clotrimazole | Clotrimazole | 24 | 23 |
| Flecainide Acetate | Flecainide Acetate | 24 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 24 | 22 |
| Fluconazole | Fluconazole | 23 | 19 |
| Paxlovid | Nirmatrelvir/Ritonavir | 23 | 23 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 22 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 22 | suppressed |
| Metronidazole | Metronidazole | 21 | 20 |
| Digoxin | Digoxin | 20 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 19 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 19 | 13 |
| Januvia | Sitagliptin Phosphate | 19 | suppressed |
| Terconazole | Terconazole | 19 | suppressed |
| Acyclovir | Acyclovir | 18 | 15 |
| Easy Touch | Syringe-Needle,insulin,0.5 Ml | 18 | suppressed |
| Jentadueto Xr | Linagliptin/Metformin Hcl | 18 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 18 | suppressed |
| Nitroglycerin | Nitroglycerin | 18 | suppressed |
| Propylthiouracil | Propylthiouracil | 18 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 18 | suppressed |
| Insulin Lispro | Insulin Lispro | 17 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 17 | suppressed |
| Lamotrigine | Lamotrigine | 17 | suppressed |
| Methimazole | Methimazole | 17 | suppressed |
| Trazodone Hcl | Trazodone Hcl | 17 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 16 | suppressed |
| Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 16 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 16 | 15 |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 15 | suppressed |
| Ampicillin Trihydrate | Ampicillin Trihydrate | 15 | 11 |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 15 | suppressed |
| Neomycin-Polymyxin-Hc | Neomycin/Polymyxin B/Hydrocort | 15 | 15 |
| Sure Comfort | Syringe And Needle,insulin,1ml | 15 | suppressed |
| Trijardy Xr | Empaglifloz/Linaglip/Metformin | 15 | suppressed |
| Easy Touch | Syring-Needl,disp,insul,0.3 Ml | 14 | suppressed |
| Etodolac | Etodolac | 14 | suppressed |
| Fluticasone Propionate Hfa | Fluticasone Propionate | 14 | suppressed |
| Ramipril | Ramipril | 14 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 14 | suppressed |
| Xarelto | Rivaroxaban | 14 | suppressed |
| Glipizide Er | Glipizide | 13 | suppressed |
| Humalog Mix 75-25 | Insulin Lispro Protamin/Lispro | 13 | suppressed |
| Kerendia | Finerenone | 13 | suppressed |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 13 | 13 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 13 | 12 |
| Lumigan | Bimatoprost | 13 | suppressed |
| Synjardy | Empagliflozin/Metformin Hcl | 13 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 13 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 13 | suppressed |
| Trueplus Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 13 | suppressed |
| Amantadine | Amantadine Hcl | 12 | suppressed |
| Entresto | Sacubitril/Valsartan | 12 | suppressed |
| Enulose | Lactulose | 12 | suppressed |
| Fluorometholone | Fluorometholone | 12 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 12 | suppressed |
| Ibu | Ibuprofen | 12 | 12 |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 12 | suppressed |
| Letrozole | Letrozole | 12 | suppressed |
| Methotrexate | Methotrexate Sodium | 12 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 12 | suppressed |
| Topiramate | Topiramate | 12 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 11 | suppressed |
| Diclofenac Potassium | Diclofenac Potassium | 11 | suppressed |
| Levo-T | Levothyroxine Sodium | 11 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 11 | suppressed |
| Trospium Chloride | Trospium Chloride | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $19.75 · 1 records | PFIZER INC. | PAXLOVID | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Paxlovid play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with PFIZER INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error